Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in the neonatal intensive care unit (NICU). It is also a major cause of preterm infant morbidity and mortality. Along with others, its driving factors include intestinal barrier immaturity, hyperinflammatory immune cells, and dysbiosis. Intestinal inflammation, frequently after enteral feeds, results in bacterial translocation of the intestinal barrier, sepsis, multiorgan failure, and sometimes death.
NEC pathophysiology remains incompletely understood even years after research progress, and treatment options are limited to surgical and supportive therapies. Infants surviving this devastating disease frequently suffer from neurodevelopmental impairment, short gut syndrome, intestinal failure, and cerebral palsy.
Recently, animal modeling in germ-free or Toll-like receptor knockout (TLR KO) mice has suggested dysbiosis' probable role in driving NEC pathogenesis. Numerous factors, modifiable and unmodifiable, affect gut microbiome development in preterm infants, including infant gestational age, mode of delivery and feeding, infant medications, and maternal and NICU environment.
Infant Gut Microbiota:
The collective intestinal microbiome assumably determines NEC pathogenesis. Unlike healthy term infants, the microbiome of preterm infants has distinct but less diverse taxa, with a progression dictated largely by postmenstrual age. Components of these host-microbe interactions cause the basal tuning of the preterm immune system to luminal contents, breakdown of the intestinal barrier, and resulting runaway intestinal epithelial inflammation characteristic of NEC.
Microbiome Detection and Identification of Biomarkers:
Volatile organic compounds (VOCs) are the recently described noninvasive fecal biomarkers of microbiome shifts that diagnose NEC even before the appearance of obvious symptoms; and can be detected via gas chromatography (GC), mass spectrometry (MS), and, very recently, electronic nose (eNose) technology. There is limited use of eNose technology in clinical applications due to non-standardized protocols for stool acquisition and differences in signals among age groups and dietary patterns. Further, elevated DL-lactate and a reduction in enzymes capable of utilizing human milk oligosaccharides (HMOs) may also emerge as the potential biomarkers of developing preterm dysbiosis and NEC.
Prebiotics, Probiotics, and Synbiotics:
Prebiotics, probiotics, and synbiotics continue to draw interest for prevention or therapeutic use in NEC because, when used in the early postnatal period, they are capable of modulating preterm infant microbiome development, thus potentially mitigating or preventing the development of NEC.
Burge KY, Markel TA. Neonatal Microbiome, Intestinal Inflammation, and Necrotizing Enterocolitis. Microorganisms. 2022 Jul 9;10(7):1382. DOI: 10.3390/microorganisms10071382. PMID: 35889101; PMCID: PMC9320150.
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details